Agilent Technologies Announces Collaboration with Florey Institute of Neuroscience and Mental Health
September 19, 2013
MELBOURNE, Australia -- Agilent Technologies Inc. (NYSE: A) today announced a collaboration with the Florey Institute of Neuroscience and Mental Health that will allow scientists to detect and measure metals at the protein level directly from tissue in neurodegenerative diseases such as motor neuron, Parkinson's and Alzheimer's. For scientists and researchers, the ability to monitor [...]
September 19, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced it has combined its Life Sciences Group with its Diagnostics and Genomics business, naming Lars Holmkvist the new group's president and senior vice president of Agilent, effective immediately. Holmkvist was previously president of the Diagnostics and Genomics Group and senior vice president of Agilent. [...]
PAC Instruments Comply with New CEN Standard, EN 16329
September 19, 2013
Houston, TX., USA – Both PAC’s Herzog HCP 842 and ISL FPP 5Gs now fully comply with the new standard, EN 16329, “Determination of CFPP for Diesel and Domestic Heating Fuels – Linear Cooling Bath Method” recently released by CEN (European Committee for Standardization). The EN 16329 is now also listed in the EN 590 [...]
September 19, 2013
NEW YORK, Sept. 19, 2013 /PRNewswire/ -- Exosome Diagnostics today announced it has entered into a collaboration agreement with Eli Lilly and Company (NYSE: LLY) for biomarker discovery and validation using Exosome Diagnostics proprietary EXO50 nucleic acid extraction kit. Under the agreement, Lilly will gain early access to Exosome Diagnostics technology to help identify key [...]
September 19, 2013
Holliston, MA -- The Oligo Factory, a provider of quality custom DNA/RNA synthesis services, announced plans to expand its facilities to accommodate growing market demand for mg to gram scale custom oligonucleotides, derivatives and modifications. The expanded facility will house additional synthesis and purification instrumentation and expand capacity to enable the company to serve its [...]
SAFC® Strengthens Biopharmaceutical Position With Innovations to Established CHOZN® Portfolio
September 19, 2013
ST. LOUIS -- Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced that SAFC® Commercial (www.sigma-aldrich.com/safc), its custom manufacturing services business unit, has engineered additional traits into its CHOZN® Platform cell line, increasing the utility of the CHOZN® portfolio of products and services. Two novel host cell lines have been added to the CHOZN® portfolio, yielded through SAFC's [...]
Agilent Technologies Names Robert Cantrell as Vice President and Treasurer
September 19, 2013
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced that Robert Cantrell has been named vice president and treasurer. Cantrell replaces Neil Dougherty, who is CFO-designate of the new electronic measurement company to be formed by the separation of Agilent into two publicly traded companies. In his new position, Cantrell will be responsible [...]
Bruker Announces the World’s First Preclinical Magnetic Particle Imaging (MPI) System
September 19, 2013
SAVANNAH, Ga. -- At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today announced the world's first Magnetic Particle Imaging (MPI) system, an entirely new technology for preclinical imaging. The addition of MPI as a complementary preclinical imaging technique for disease studies, translational research and drug discovery, has significant potential in helping researchers gain [...]
Cellectricon announces Cellaxess® ACE project grant winners
September 19, 2013
Molndal, Sweden -- Cellectricon, a leading provider of advanced cell-based screening technologies and services, has announced the two winners of its Cellaxess® ACE project grant, supporting cutting-edge research in cell biology. The grant was awarded for project proposals utilizing Cellectricon’s Cellaxess ACE technology for the delivery of non-genetic material to adherent cells and cultures. The [...]
Ehrfeld Mikrotechnik BTS and Alfa Laval cooperate in millireactor technology
September 18, 2013
Wendelsheim (Germany) – Ehrfeld Mikrotechnik BTS GmbH (EMB), a subsidiary of Bayer Technology Services GmbH, has acquired a worldwide license from Alfa Laval to market and manufacture ART® reactor technology. With these millistructured plate reactors, which are used in laboratory, pilot and production plants, EMB is now the leading supplier of metal micro- and millistructured [...]
